BELLICUM PHARMACEUTICALS, INC 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Feb 1, 2017
Insider Transaction Report
Form 4
Fair Richard A.
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2017-01-30+500,000→ 500,000 totalExercise: $11.87Exp: 2027-01-29→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on January 30, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.